Literature DB >> 33679050

Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Pankaj Puri1, Radha K Dhiman2, Sunil Taneja3, Puneeta Tandon4, Manuela Merli5, Anil C Anand6, Anil Arora7, Subrat K Acharya1, Jaya Benjamin8, Yogesh K Chawla6, Sunil Dadhich9, Ajay Duseja3, C E Eapan10, Amit Goel2, Naveen Kalra3, Dharmesh Kapoor11, Ashish Kumar7, Kaushal Madan12, Aabha Nagral13, Gaurav Pandey2, Padaki N Rao14, Sanjiv Saigal15, Neeraj Saraf15, Vivek A Saraswat2, Anoop Saraya16, Shiv K Sarin8, Praveen Sharma7, Akash Shukla17, Sandeep S Sidhu18, Namrata Singh16, Shivaram P Singh19, Anshu Srivastava2, Manav Wadhawan20.   

Abstract

Malnutrition and sarcopenia are common in patients with chronic liver disease and are associated with increased risk of decompensation, infections, wait-list mortality and poorer outcomes after liver transplantation. Assessment of nutritional status and management of malnutrition are therefore essential to improve outcomes in patients with chronic liver disease. This consensus statement of the Indian National Association for Study of the Liver provides a comprehensive review of nutrition in chronic liver disease and gives recommendations for nutritional screening and treatment in specific clinical scenarios of malnutrition in cirrhosis in adults as well as children with chronic liver disease and metabolic disorders.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V.

Entities:  

Keywords:  ACLF, acute on chronic liver failure; ASM, appendicular skeletal muscle mass; BCAA, branched chain amino acids; BIA, bioimpedance analysis; BMD, bone mineral densitometry; BMI, body mass index; CLD, chronic liver disease; CS, corn-starch; CT, computed tomography; CTP, Child–Turcotte–Pugh; DEXA, dual-energy X-ray absorptiometry; EASL, European Association for the Study of the Liver; ESPEN, European society for Clinical Nutrition and Metabolism; GSD, glycogen storage disease; HGS, hand-grip strength; IBW, ideal body weight; IEM, inborn error of metabolism; INASL, Indian National Association for Study of the Liver; L3, third lumbar; LFI, Liver Frailty Index; MCT, medium-chain triglyceride; MELD, model for end-stage liver disease; MLD, metabolic liver disease; MRI, magnetic resonance imaging; RDA, recommended daily allowance; REE, NASH; RFH-NPT, Royal Free Hospital-Nutritional Prioritizing Tool; SMI, skeletal muscle index; Sarcopenia; TEE, total energy expenditure; chronic liver disease; cirrhosis; malnutrition; non-alcoholic liver disease, resting energy expenditure; nutrition

Year:  2020        PMID: 33679050      PMCID: PMC7897902          DOI: 10.1016/j.jceh.2020.09.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  340 in total

1.  Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.

Authors:  Ho Cheol Hong; Soon Young Hwang; Hae Yoon Choi; Hye Jin Yoo; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Hepatology       Date:  2014-03-24       Impact factor: 17.425

2.  Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue.

Authors:  Dympna Gallagher; Patrick Kuznia; Stanley Heshka; Jeanine Albu; Steven B Heymsfield; Bret Goodpaster; Marjolein Visser; Tamara B Harris
Journal:  Am J Clin Nutr       Date:  2005-04       Impact factor: 7.045

3.  Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension.

Authors:  J C García-Pagàn; C Santos; J A Barberá; A Luca; J Roca; R Rodriguez-Roisin; J Bosch; J Rodés
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

4.  Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria.

Authors:  Hiroki Nishikawa; Makoto Shiraki; Akira Hiramatsu; Kyoji Moriya; Keisuke Hino; Shuhei Nishiguchi
Journal:  Hepatol Res       Date:  2016-09       Impact factor: 4.288

5.  Comparing assessment tools for detecting undernutrition in patients with liver cirrhosis.

Authors:  M McFarlane; C Hammond; T Roper; J Mukarati; R Ford; J Burrell; V Gordon; N Burch
Journal:  Clin Nutr ESPEN       Date:  2017-11-02

Review 6.  Glucose homeostasis in the newborn.

Authors:  Robert Hume; Ann Burchell; Fiona L R Williams; Daisy K M Koh
Journal:  Early Hum Dev       Date:  2004-11-19       Impact factor: 2.079

Review 7.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

8.  Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study.

Authors:  Filippo Morando; Silvia Rosi; Elisabetta Gola; Mariateresa Nardi; Salvatore Piano; Silvano Fasolato; Marialuisa Stanco; Marta Cavallin; Antonietta Romano; Antonietta Sticca; Lorenza Caregaro; Angelo Gatta; Paolo Angeli
Journal:  Liver Int       Date:  2014-05-21       Impact factor: 5.828

9.  Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction.

Authors:  Nimer Assy; Yosef Pruzansky; Diana Gaitini; Zila Shen Orr; Ze'ev Hochberg; Yaacov Baruch
Journal:  J Hepatol       Date:  2008-03-27       Impact factor: 25.083

10.  A Model to Identify Sarcopenia in Patients With Cirrhosis.

Authors:  Puneeta Tandon; Gavin Low; Marina Mourtzakis; Laura Zenith; Robert P Myers; Juan G Abraldes; Abdel Aziz M Shaheen; Hina Qamar; Nadia Mansoor; Michelle Carbonneau; Kathleen Ismond; Sumeer Mann; Alshimaa Alaboudy; Mang Ma
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-14       Impact factor: 11.382

View more
  5 in total

Review 1.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

Review 2.  Extrahepatic Manifestations in Alcoholic Liver Disease.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-02-25

3.  Untangling the Web of Malnutrition, Sarcopenia, and Frailty in Chronic Liver Disease.

Authors:  Vivek A Saraswat; Karan Kumar
Journal:  J Clin Exp Hepatol       Date:  2022-03-17

Review 4.  An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist.

Authors:  Pankaj Puri; Narendra Kotwal
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

Review 5.  Clinical and biomarker assessment of frailty in liver transplantation.

Authors:  Tumininu Ayorinde; Guergana Panayotova; Aanchal Sharma; Keri E Lunsford
Journal:  Curr Opin Organ Transplant       Date:  2021-10-01       Impact factor: 2.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.